Health Canada's Substance Use and Addictions Program (SUAP) has awarded the National Pain Centre $545,977, over the course of 18 months, to update the 2017 Canadian Guideline on the use of opioids for non-cancer pain, incorporating new evidence and adopting new knowledge synthesis methods, as well as incorporating information from stakeholder feedback. The updated guideline will provide essential information to people living with chronic pain, and physicians, nurse practitioners, and pharmacists involved in their care.
Canadians are the second highest users per capita of opioids in the world. The 2017 Canadian Guideline for Opioid for Chronic Non-Cancer Pain was developed to optimize evidence-based prescribing of opioids for chronic non-cancer pain and recommendations for clinical practice were developed by an international team of clinicians, researchers and patients.
Work on the revised guideline has already begun and will be completed in 2023.